Alkermes plc’s recent filing unveils that its EVP R&D, Chief Medical Officer Hopkinson Craig C. unloaded Company’s shares for reported $3.23 million on Jan 30 ’25. In the deal valued at $32.05 per share,100,918 shares were sold. As a result of this transaction, Hopkinson Craig C. now holds 44,290 shares worth roughly $1.36 million.
Then, Hopkinson Craig C. bought 100,918 shares, generating $3,234,380 in total proceeds.
Before that, Hopkinson Craig C. sold 61,151 shares. Alkermes plc shares valued at $1,961,406 were divested by the EVP R&D, Chief Medical Officer at a price of $32.07 per share. As a result of the transaction, Hopkinson Craig C. now holds 47,576 shares, worth roughly $1.46 million.
Stifel upgraded its Alkermes plc [ALKS] rating to a Buy from a a Hold in a research note published on November 05, 2024; the price target was increased to $36 from $25. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Robert W. Baird began covering ALKS with “an Outperform” recommendation on March 19, 2024. UBS revised its rating on February 20, 2024. It rated ALKS as “a Sell” which previously was an “a Neutral”.
Price Performance Review of ALKS
On Monday, Alkermes plc [NASDAQ:ALKS] saw its stock fall -2.44% to $30.76. Over the last five days, the stock has lost -2.41%. Alkermes plc shares have risen nearly 6.95% since the year began. Nevertheless, the stocks have risen 13.72% over the past one year. While a 52-week high of $32.88 was reached on 01/30/25, a 52-week low of $22.90 was recorded on 01/13/25. SMA at 50 days reached $29.81, while 200 days put it at $27.06.
Levels Of Support And Resistance For ALKS Stock
The 24-hour chart illustrates a support level at 30.33, which if violated will result in even more drops to 29.89. On the upside, there is a resistance level at 31.19. A further resistance level may holdings at 31.61. The Relative Strength Index (RSI) on the 14-day chart is 54.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.25%. Stochastics %K at 81.21% indicates the stock is a selling.
How much short interest is there in Alkermes plc?
A steep rise in short interest was recorded in Alkermes plc stocks on 2025-01-15, dropping by -1.13 million shares to a total of 11.37 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 12.5 million shares. There was a decline of -9.97%, which implies that there is a negative sentiment for the stock.
